Sign in
4

Changes in Ownership

Wave Life Sciences, Inc. Filed Acc 0000950170-24-110141

Chief Financial Officer sold 17,146 shares at $9.00 ($154,314)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Moran Kyle Chief Financial Officer 2024-09-25 Sale 10b5-1 −17,146 $9.00 $154,314 19,777 D
Open-market sales · 17,146 sh · avg $9.00 · $154,314
Loading xslF345X05/ownership.xml…